Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
5992.0000 77.50 (1.31%)
NSE Aug 11, 2025 15:31 PM
Volume: 677.7K
 

5992.00
1.31%
Axis Direct
Q4 revenue declined 3% YoY in line with our estimate, while EBITDA adjusted for Rs 290 mn of forex loss at Rs 3.9 bn was 9% below our estimate. Adj. PAT declined 10% YoY at Rs 2.88 bn, 12% below our estimate.
Divi's Laboratories .. has an average target of 6447.40 from 5 brokers.
More from Divi's Laboratories Ltd.
Recommended